A novel drug for urticaria therapy—Ligelizumab

doi:10.3969/j.issn.1672-3384.2022.06.002

PDF(365 KB)

Clinical Medication Journal ›› 2022, Vol. 20 ›› Issue (6) : 7-10. DOI: 10.3969/j.issn.1672-3384.2022.06.002

Comment of New Drug

A novel drug for urticaria therapy—Ligelizumab

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2022, 20(6): 7-10 https://doi.org/10.3969/j.issn.1672-3384.2022.06.002

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(365 KB)

Accesses

Citation

Detail

Sections

Recommended

Please choose a citation manager

Content to export